155 related articles for article (PubMed ID: 36295655)
1. The Role of miR-375-3p, miR-210-3p and Let-7e-5p in the Pathological Response of Breast Cancer Patients to Neoadjuvant Therapy.
Lisencu LA; Roman A; Visan S; Bonci EA; Pașca A; Grigorescu E; Mustea E; Cismaru A; Irimie A; Lisencu C; Balacescu L; Balacescu O; Tudoran O
Medicina (Kaunas); 2022 Oct; 58(10):. PubMed ID: 36295655
[No Abstract] [Full Text] [Related]
2. MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations.
Ozcan O; Kara M; Yumrutas O; Bozgeyik E; Bozgeyik I; Celik OI
Tumour Biol; 2016 May; 37(5):6637-45. PubMed ID: 26643896
[TBL] [Abstract][Full Text] [Related]
3. Different levels of serum microRNAs in prostate cancer and benign prostatic hyperplasia: evaluation of potential diagnostic and prognostic role.
Cochetti G; Poli G; Guelfi G; Boni A; Egidi MG; Mearini E
Onco Targets Ther; 2016; 9():7545-7553. PubMed ID: 28008272
[TBL] [Abstract][Full Text] [Related]
4. Mammographic assessment of breast density as a tool for predicting the response to neoadjuvant therapy in breast cancer patients.
Lisencu LA; Roman A; Paşca A; Irimie A; Lisencu C; Negrutiu M; Fetica B; Cismaru A; Balacescu O; Tudoran O; Lisencu C
Med Pharm Rep; 2024 Jan; 97(1):43-55. PubMed ID: 38344331
[TBL] [Abstract][Full Text] [Related]
5. Identification of high-grade serous ovarian cancer miRNA species associated with survival and drug response in patients receiving neoadjuvant chemotherapy: a retrospective longitudinal analysis using matched tumor biopsies.
Petrillo M; Zannoni GF; Beltrame L; Martinelli E; DiFeo A; Paracchini L; Craparotta I; Mannarino L; Vizzielli G; Scambia G; D'Incalci M; Romualdi C; Marchini S
Ann Oncol; 2016 Apr; 27(4):625-34. PubMed ID: 26782955
[TBL] [Abstract][Full Text] [Related]
6. Meta-microRNA Biomarker Signatures to Classify Breast Cancer Subtypes.
Oztemur Islakoglu Y; Noyan S; Aydos A; Gur Dedeoglu B
OMICS; 2018 Nov; 22(11):709-716. PubMed ID: 30388053
[TBL] [Abstract][Full Text] [Related]
7. Circulating Small EVs miRNAs as Predictors of Pathological Response to Neo-Adjuvant Therapy in Breast Cancer Patients.
Baldasici O; Balacescu L; Cruceriu D; Roman A; Lisencu C; Fetica B; Visan S; Cismaru A; Jurj A; Barbu-Tudoran L; Pileczki V; Vlase L; Tudoran O; Balacescu O
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293478
[TBL] [Abstract][Full Text] [Related]
8. Integrated Microarray-Based Data Analysis of miRNA Expression Profiles: Identification of Novel Biomarkers of Cisplatin-Resistance in Testicular Germ Cell Tumours.
Roška J; Lobo J; Ivovič D; Wachsmannová L; Mueller T; Henrique R; Jerónimo C; Chovanec M; Jurkovičová D
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768818
[TBL] [Abstract][Full Text] [Related]
9. Molecular pathogenesis of breast cancer: impact of miR-99a-5p and miR-99a-3p regulation on oncogenic genes.
Shinden Y; Hirashima T; Nohata N; Toda H; Okada R; Asai S; Tanaka T; Hozaka Y; Ohtsuka T; Kijima Y; Seki N
J Hum Genet; 2021 May; 66(5):519-534. PubMed ID: 33177704
[TBL] [Abstract][Full Text] [Related]
10. Using biological information to analyze potential miRNA-mRNA regulatory networks in the plasma of patients with non-small cell lung cancer.
Zhang W; Zhang Q; Che L; Xie Z; Cai X; Gong L; Li Z; Liu D; Liu S
BMC Cancer; 2022 Mar; 22(1):299. PubMed ID: 35313857
[TBL] [Abstract][Full Text] [Related]
11. RNA-sequence-based microRNA expression signature in breast cancer: tumor-suppressive miR-101-5p regulates molecular pathogenesis.
Toda H; Seki N; Kurozumi S; Shinden Y; Yamada Y; Nohata N; Moriya S; Idichi T; Maemura K; Fujii T; Horiguchi J; Kijima Y; Natsugoe S
Mol Oncol; 2020 Feb; 14(2):426-446. PubMed ID: 31755218
[TBL] [Abstract][Full Text] [Related]
12. Circulating let-7e-5p, miR-106a-5p, miR-28-3p, and miR-542-5p as a Promising microRNA Signature for the Detection of Colorectal Cancer.
Silva CMS; Barros-Filho MC; Wong DVT; Mello JBH; Nobre LMS; Wanderley CWS; Lucetti LT; Muniz HA; Paiva IKD; Kuasne H; Ferreira DPP; Cunha MPSS; Hirth CG; Silva PGB; Sant'Ana RO; Souza MHLP; Quetz JS; Rogatto SR; Lima-Junior RCP
Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33804927
[TBL] [Abstract][Full Text] [Related]
13. The transcardiac gradient of cardio-microRNAs in the failing heart.
Marques FZ; Vizi D; Khammy O; Mariani JA; Kaye DM
Eur J Heart Fail; 2016 Aug; 18(8):1000-8. PubMed ID: 27072074
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of miR-125a-5p and let-7e predicts the progression and prognosis of non-small cell lung cancer.
Zhu WY; Luo B; An JY; He JY; Chen DD; Xu LY; Huang YY; Liu XG; Le HB; Zhang YK
Cancer Invest; 2014 Oct; 32(8):394-401. PubMed ID: 24945821
[TBL] [Abstract][Full Text] [Related]
15. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
16. Circulating hsa-let-7e-5p and hsa-miR-125a-5p as Possible Biomarkers in the Diagnosis of Major Depression and Bipolar Disorders.
Gecys D; Dambrauskiene K; Simonyte S; Patamsyte V; Vilkeviciute A; Musneckis A; Butkute-Sliuoziene K; Lesauskaite V; Zemaitis L; Usaite D; Adomaitiene V
Dis Markers; 2022; 2022():3004338. PubMed ID: 35178127
[TBL] [Abstract][Full Text] [Related]
17. Small extracellular vesicle-encapsulated miR-181b-5p, miR-222-3p and let-7a-5p: Next generation plasma biopsy-based diagnostic biomarkers for inflammatory breast cancer.
Ahmed SH; Espinoza-Sánchez NA; El-Damen A; Fahim SA; Badawy MA; Greve B; El-Shinawi M; Götte M; Ibrahim SA
PLoS One; 2021; 16(4):e0250642. PubMed ID: 33901254
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-Seq Data Analysis Pipeline to Identify Blood Biomarkers for Alzheimer's Disease from Public Data.
Satoh J; Kino Y; Niida S
Biomark Insights; 2015; 10():21-31. PubMed ID: 25922570
[TBL] [Abstract][Full Text] [Related]
19. [The Interaction of miRNA-5p and miRNA-3p with the mRNAs of Orthologous Genes].
Yurikova OY; Aisina DE; Niyazova RE; Atambayeva SA; Labeit S; Ivashchenko AT
Mol Biol (Mosk); 2019; 53(4):692-704. PubMed ID: 31397443
[TBL] [Abstract][Full Text] [Related]
20. A microRNA signature associated with pathological complete response to novel neoadjuvant therapy regimen in triple-negative breast cancer.
García-Vazquez R; Ruiz-García E; Meneses García A; Astudillo-de la Vega H; Lara-Medina F; Alvarado-Miranda A; Maldonado-Martínez H; González-Barrios JA; Campos-Parra AD; Rodríguez Cuevas S; Marchat LA; López-Camarillo C
Tumour Biol; 2017 Jun; 39(6):1010428317702899. PubMed ID: 28621239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
